METABOLIC DISEASES AND HYPERTENSION: ANALYZING PATIENTS AND EXPLORING THEIR PROSPECTS

Abstract

Hypertension (HT) is one of the most widespread and serious health problems globally, characterized by a persistent increase in blood pressure. In recent decades, there has been growing attention to the impact of metabolic diseases on the course and prognosis of hypertension. Metabolic abnormalities such as dyslipidemia, carbohydrate metabolism disorders, and obesity often accompany hypertension, increasing the risk of cardiovascular complications.

The aim of this review is to systematize current knowledge regarding metabolic diseases in patients with hypertension, analyze their mutual underlying mechanisms, and discuss promising research directions in this area. The research methods include an analysis of recent scientific publications and review articles available in medical databases.

The results of the analysis emphasize the importance of early detection and effective management of metabolic diseases in patients with hypertension. Dyslipidemia, insulin resistance, and obesity significantly impact the course of hypertension and increase the risk of cardiovascular complications. Particular attention is given to the interrelated mechanisms between these conditions, which is crucial for developing personalized approaches to treatment and prevention.

In conclusion, the need for further research focused on developing new methods for diagnosing, preventing, and treating metabolic diseases in patients with hypertension is highlighted. Optimizing the management of metabolic factors can significantly reduce the burden of disease and improve the prognosis for patients suffering from hypertension and accompanying metabolic disorders.